Skip to main content
Clinical Trials/NCT02037360
NCT02037360
Completed
Not Applicable

Mobile Mindfulness Training for Smoking Cessation

University of Massachusetts, Worcester1 site in 1 country1,251 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
University of Massachusetts, Worcester
Enrollment
1251
Locations
1
Primary Endpoint
Point prevalence abstinence at 6 months
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to assess the effectiveness of a Mobile Mindfulness Training smartphone application on smoking cessation in smokers ages 18 to 65 years.

Detailed Description

In this study, a pilot phase will be carried out first to test feasibility and engagement of the tested intervention. Then in the randomized control trial, subjects will be randomly assigned to receive one of two treatments: (1) a standard smartphone application to support smokers working to become quit-free, or (2) the tested intervention, an app that trains mindfulness for smoking cessation. The primary endpoint of interest will be 1-week point prevalence abstinence at end of treatment, and at 3 and 6 months follow-up for individuals.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
December 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Massachusetts, Worcester
Responsible Party
Principal Investigator
Principal Investigator

Judson Brewer

Director of Research, Center for Mindfulness

University of Massachusetts, Worcester

Eligibility Criteria

Inclusion Criteria

  • Participants must be (a) 18-65 years of age; (b) smoke 5+ cigarettes/day, (c) \< 3 months abstinence in the past year; (d) have a smartphone; and motivated to quit smoking.

Exclusion Criteria

  • There are no exclusion criteria. We aim to recruit a heterogeneous group, representative of the general population.

Outcomes

Primary Outcomes

Point prevalence abstinence at 6 months

Time Frame: 6 months after beginning treatment

Subjects will be assessed for smoking abstinence at a 6-month follow-up.

Secondary Outcomes

  • Point prevalence abstinence at 3 months(3 months after beginning treatment)

Study Sites (1)

Loading locations...

Similar Trials